2013 Archived Content
Mark Your Calendar! The 10th Annual microRNA Conference will be held March 17-18, 2014 at the Omni Parker House in Boston, MA.
microRNAs are playing an important role in a range of diseases such as cancer, metabolic diseases and cardiovascular disorders. Their involvement in many physiological pathways, makes them an excellent target for pharmaceutical drug development and their use as biomarkers or for profiling and screening turns them into a valuable tool for diagnostics. This conference highlights the latest developments in using miRNA's for health and disease, the novel applications and progress made in manipulating microRNA, and the opportunities for using microRNA as a tool.
20+ SCIENTIFIC PRESENTATIONS COVERING:
- Therapeutic Potential in Inflammation, Cancer and Pain
- New Technological Strategies
- microRNAs as Biomarkers and in Diagnostics
- Tissue-Based Analysis
- Circulating miRNAs
SHORT COURSE:
Sunday, March 3
2:00 - 5:00 pm Computational Aspects of microRNA
Computational Analysis of Noncoding RNA
Stefan Washietl, Ph.D., Scientist, Computational Biology, Massachusetts Institute of Technology
Using a Bioinformatics Resource Manager
Susan C. Tilton, Ph.D., Scientist, Computational Biology & Bioinformatics, Pacific Northwest National Laboratory
BioVLAB-MMIA: a Cloud Environment for microRNA and mRNA Integrated Analysis (MMIA) on Amazon EC2
Hyungro Lee, Ph.D., Pervasive Technology Institute, School of Informatics and Computing, Indiana University
AGENDA HIGHLIGHTS:
microRNAs in Diagnostics and Targeting Rheumatic Disease
Steffen Gay, M.D., Professor, Experimental Rheumatology, University of Zurich
Causes and Consequences of microRNA Dysregulation in Cancer
Carlo M. Croce, M.D., Professor and Chair, Department of Molecular Virology, Immunology and Medical Genetics; Director, Institute of Genetics,Ohio State University
Pre-Clinical Development of a Tumor Suppressor miRNA
David Brown, Ph.D., Director, Research, Mirna Therapeutics
microRNAs: Novel Target Class for Small Molecule Drug Discovery?
Pramod Pandey, Ph.D., Senior Research Investigator, Center for Proteomic Chemistry, Integrated Lead Discovery, Novartis Institute for Biomedical Research, Inc.
Circulating miRNAs as Biomarkers: How Far Have We Made It?
Igor Mikaelian, M.D., D.V.M., MSc, DACVP, Research Leader, Hoffman-La Roche, Inc.
Extracting Contextual microRNA Information for Cancer Diagnostics
Lorenzo F. Sempere, Ph.D., Research Assistant Professor, Department of Medicine, Geisel School of Medicine at Dartmouth